Arthur N. Brodsky, PhD Associate Director, Scientific Content Dr. Arthur N. Brodsky is the associate director, scientific content, at the Cancer Research Institute. He joined the CRI team in November 2015 as science writer before assuming roles of incresing responsibility supporting the organization’s scientific and medical communications priorities. He is passionate about translating the exciting advances in cancer immunotherapy to increase awareness and appreciation of these potentially lifesaving breakthroughs. His belief in the power of immunotherapy―and the importance of communicating the science clearly―inspired him to give a TEDx Talk on the subject. Prior to joining CRI, Arthur earned his PhD in bioengineering at Clemson University, where he focused on breast cancer metabolism, stem cell expansion, and biopharmaceutical production. He also received his M.S. in bioengineering from Clemson University and his B.S. in biomedical engineering from the University of Miami. Selected Articles & Stories: The Rules of the Game: Dr. Robert Schreiber, Interferon Gamma, and Our Quest to Cure Cancer CRI Speaks with 2019 AACR-CRI Lloyd J. Old Award Recipient, Dr. Cornelis ‘Kees’ Melief CRI-Funded Trial Reveals Promising Potential of Immunotherapy Combination in Metastatic Pancreatic Cancer Dr. James P. Allison, CRI Scientific Director, Awarded 2018 Nobel Prize along with Dr. Tasuku Honjo How Man’s Best Friend Could Help Us Cure Cancer Immunotherapy Webinars (Host & Content Creator): “Personalized Cancer Treatment” with Dr. Patrick Hwu “Immunotherapy: A Look at the Year Ahead for 2019” with Dr. Elizabeth Jaffee “Antibody-Based Therapies” with Dr. Rony Dahan “Cancer Vaccines” with Dr. Gavin P. Dunn “Biomarkers in Cancer Immunotherapy” with Dr. Kunle Odunsi “Cellular Immunotherapies” with Dr. Philip D. Greenberg Selected Journal Publications (Corresponding Author): The Seventh Annual AACR—CRI Lloyd J. Old Award in Cancer Immunology Translating Science into Survival: Report on the Fourth International Cancer Immunotherapy Conference The Sixth Annual AACR–CRI Lloyd J. Old Award in Cancer Immunology Translating Science into Survival: Report on the Third International Cancer Immunotherapy Conference